Does NGS report molecular rearrangements as an all or none phenomenon? What is the importance of subclones as far as interpretation of genomic profiles of tumors? (Spanish)

Does NGS report molecular rearrangements as an all or none phenomenon? What is the importance of subclones as far as interpretation of genomic profiles of tumors? (Spanish)

Does NGS report molecular rearrangements as an all or none phenomenon? What is the importance of subclones as far as interpretation of genomic profiles of tumors? (Spanish)


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Prof. Jordi Rodon, MD

Prof. Jordi Rodon, MD

Director and Clinical Head
Research Unit for Molecular Therapy of Cancer
Head, Early Clinical Drug Development Group
Vall d'Hebron Institute of Oncology
Associate Professor of Oncology
International University of Catalonia
Barcelona, Spain